Internal Medicine, Gastroenterology · West Hollywood, CA
NPI
1083865836
Since 2008
Specialty
Internal Medicine, Gastroenterology
Code 207RG0100X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
8700 Beverly Blvd
West Hollywood, CA, 90048
Phone (310) 423-4611
Groups this clinician bills Medicare through
Medicare paid, 2024
$105K
1,083 services
Medicare patients, 2024
453
Average age 71
Drug cost, 2024
$467K
1,316 prescriptions
Company payments, 2025
$346
From 4 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Marc C Kaneshiro was code G2211 (visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's), 177 times for 148 patients. In total Marc C Kaneshiro billed 1,083 services in 52 codes, and Medicare paid $105K.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2015-08-11.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|---|---|---|---|---|
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 177 | 148 | $13.24 | $2,343 |
| 45380 Lower GI Endoscopy - Other | Facility | 130 | 130 | $80.15 | $10K |
| 43239 Upper GI Endoscopy | Facility | 112 | 109 | $76.96 | $8,620 |
| 99215 Office E&M - Established | Office | 97 | 72 | $141.37 | $14K |
| 45385 Colonoscopy - Lesion Removal | Facility | 90 | 90 | $196.20 | $18K |
| 99204 Office E&M - New | Office | 85 | 85 | $133.50 | $11K |
| 99214 Office E&M - Established | Office | 71 | 52 | $101.22 | $7,187 |
| 99232 Hospital E&M - Subsequent | Facility | 49 | 34 | $64.89 | $3,180 |
| 99223 Hospital E&M - Initial | Facility | 42 | 41 | $142.72 | $5,994 |
| 99222 Hospital E&M - Initial | Facility | 30 | 30 | $107.64 | $3,229 |
| 99421 Office/Outpatient Services | Office | 26 | 18 | $11.76 | $306 |
| 99443 Telephone Services | Office | 22 | 17 | $108.21 | $2,381 |
| 45390 Lower GI Endoscopy - Other | Facility | 15 | 15 | $286.54 | $4,298 |
| 99205 Office E&M - New | Office | 13 | 13 | $174.10 | $2,263 |
| 99233 Hospital E&M - Subsequent | Facility | 12 | 11 | $97.54 | $1,171 |
By year: 2022 $98K for 837 services; 2023 $98K for 867 services; 2024 $105K for 1,083 services.
Medicare prescription drug claims, 2024
In 2024, the drug Marc C Kaneshiro prescribed most often to Medicare patients was Omeprazole, with 317 prescriptions and refills. In total Marc C Kaneshiro wrote 1,316 Medicare prescriptions that cost $467K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Omeprazole Generic | 317 | 794 | 127 | $4,728 |
| Pantoprazole Sodium Generic | 148 | 324 | 44 | $2,463 |
| Gavilyte-C Peg3350/Sod Sulf,bicarb,cl/Kcl | 121 | 121 | 106 | $2,792 |
| Motegrity Prucalopride Succinate | 90 | 146 | 22 | $78K |
| Linzess Linaclotide | 77 | 120 | 20 | $69K |
| Famotidine Generic | 67 | 190 | 25 | $1,332 |
| Dicyclomine Hcl Generic | 31 | 49 | 15 | $898 |
| Ondansetron Odt Ondansetron | 29 | 29 | Under 11 | $566 |
| Mesalamine Generic | 28 | 74 | Under 11 | $15K |
| Ondansetron Hcl Generic | 25 | 27 | Under 11 | $305 |
| Creon Lipase/Protease/Amylase | 24 | 34 | Under 11 | $78K |
| Dexlansoprazole Dr Dexlansoprazole | 23 | 50 | Under 11 | $7,471 |
| Pyridostigmine Bromide Generic | 20 | 28 | Under 11 | $1,034 |
| Mercaptopurine Generic | 15 | 23 | Under 11 | $1,164 |
| Ibsrela Tenapanor Hcl | 15 | 15 | Under 11 | $25K |
Brand drugs: - claims; generic drugs: 1,033 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Marc C Kaneshiro $346 ($346 in general payments such as food, travel and fees) from 4 companies. The largest payer was Genzyme Corporation with $144.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.